Pluristem Therapeutics Inc. (PSTI): Celgene's And Osiris' IP Positions ... Seeking Alpha As testimony to stem cell research and development achieving greater status, Novartis AG (NVS) just announced a licensing arrangement with privately-held Regenerex for access to its technology for kidney transplantation to augment in-house cell therapy ... |
